Nasrat Hakim
Vermögen: 76 Mio $ am 31.05.2026
Vermögen: 76 Mio $ am 31.05.2026
Nasrat A. Hakim is the founder of Mikah Pharma LLC, which was founded in 2009.
He held the title of President & Chief Executive Officer from 2009 to 2017.
Currently, Mr. Hakim is the Chairman, President & Chief Executive Officer at Elite Pharmaceuticals, Inc. since 2013.
In the past, he worked as the Executive Director-Quality Unit at Theratechnologies, Inc. from 1997 to 2004.
From 2004 to 2013, he served as the International Vice President-Quality Assurance at Actavis, Inc. He also worked as the Global VP-Quality & Regulatory Compliance at Zoetis Products LLC from 2004 to 2007.
Additionally, Mr. Hakim held the position of Vice President-Quality at Alexza Pharmaceuticals, Inc. and Global VP-Quality & Regulatory Compliance at Alpharma LLC.
He obtained his graduate degree from St. Thomas University School of Law in 2006 and completed his undergraduate and graduate degrees at California State University-Sacramento.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
ELITE PHARMACEUTICALS, INC. 20,57 % | 30.06.2025 | 221 572 397 ( 20,57 % ) | 76 Mio $ | 31.05.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
| ELITE PHARMACEUTICALS, INC. | Vorstandsvorsitzender | 02.08.2013 |
| Unternehmen | Position | Ende |
|---|---|---|
Mikah Pharma LLC
Mikah Pharma LLC Pharmaceuticals: MajorHealth Technology Manufactures drugs for medicines | Vorstandsvorsitzender | 01.05.2017 |
Actavis, Inc.
Actavis, Inc. Pharmaceuticals: MajorHealth Technology Manufactures generic, brand and biologic pharmaceutical products | Corporate Officer/Principal | 01.01.2013 |
Zoetis Products LLC
Zoetis Products LLC Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals | Compliance Officer | 01.01.2007 |
| THERATECHNOLOGIES INC. | Corporate Officer/Principal | 01.01.2004 |
Alpharma LLC
Alpharma LLC Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Corporate Officer/Principal | - |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 9 |
|---|---|
Actavis, Inc.
Actavis, Inc. Pharmaceuticals: MajorHealth Technology Manufactures generic, brand and biologic pharmaceutical products | Health Technology |
Zoetis Products LLC
Zoetis Products LLC Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals | Health Technology |
Elite Pharmaceuticals, Inc.
Elite Pharmaceuticals, Inc. Pharmaceuticals: GenericHealth Technology Develops and manufactures generic pharmaceutical products | Health Technology |
Theratechnologies, Inc.
Theratechnologies, Inc. Pharmaceuticals: MajorHealth Technology Operates as a specialty pharmaceutical company that discovers and develops innovative therapeutic peptide products, with an emphasis on growth-hormone releasing factor peptides | Health Technology |
Alexza Pharmaceuticals, Inc.
Alexza Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops therapies for the acute treatment of central nervous system conditions | Health Technology |
California State University-Sacramento
California State University-Sacramento Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Mikah Pharma LLC
Mikah Pharma LLC Pharmaceuticals: MajorHealth Technology Manufactures drugs for medicines | Health Technology |
St. Thomas University School of Law
St. Thomas University School of Law Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Alpharma LLC
Alpharma LLC Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen